Patent · US Active

Methods and pharmaceutical compositions for the treatment of hypertension

US9212361B2 · kind B2 · utility

1Cited by

0References

3Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
UNIVERSITÉ PARIS DIDEROT—PARIS 7 · FR
UNIVERSITE DE PARIS DESCARTES · FR

Inventors

Frederic Jaisser · Paris, FR
Nicolette Farman · Paris, FR
Antoine Tarjus · Paris, FR

Key dates

Filing date	Apr 18, 2013
Grant date	Dec 15, 2015
Priority date	—
Expiry date	Apr 18, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/30
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to an inhibitor of Neutrophil Gelatinase-Associated Lipocalin (NGAL) activity or expression for use in a method for treating or preventing hypertension in a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.